The role of EphA2 in KRAS mutant non-small cell lung cancer

被引：0

作者：

Amato, Katherine ^{[1
]}

Wang, Shan ^{[1
]}

Hastings, Andrew ^{[1
]}

Chen, Haiying ^{[2
]}

Colvin, Daniel ^{[1
]}

Ye, Fei ^{[1
]}

Chen, Jin ^{[1
]}

机构：

[1] Vanderbilt Univ, Nashville, TN 37235 USA

[2] Univ Melbourne, Melbourne, Vic, Australia

来源：

MOLECULAR CANCER RESEARCH | 2014年 / 12卷

关键词：

D O I：

10.1158/1557-3125.RASONC14-A01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A01

引用

页数：1

共 50 条

[41] De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer
Singh, Anju
Ruiz, Christian
Bhalla, Kavita
Haley, John A.
Li, Qing Kay
Acquaah-Mensah, George
Montal, Emily
Sudini, Kuladeep R.
Skoulidis, Ferdinandos
Wistuba, Ignacio I.
Papadimitrakopoulou, Vassiliki
Heymach, John V.
Boros, Laszlo G.
Gabrielson, Edward
Carretero, Julian
Wong, Kwok-Kin
Haley, John D.
Biswal, Shyam
Girnun, Geoffrey D.
FASEB JOURNAL, 2018, 32 (12): : 7018 - 7027
[42] A pooled shRNA screen for erlotinib sensitizers in Kras-mutant non-small cell lung cancer
Cordes, Shaun
Dompe, Nick
Lee, James
Li, Li
Rivers, Celina
Tang, Zhijun
Luk, Wilman
Bennett, Greg
Shames, David
Modrusan, Zora
Davis, David P.
CANCER RESEARCH, 2010, 70
[43] KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
Rosell, Rafael
Codony-Servat, Jordi
Gonzalez, Jessica
Santarpia, Mariacarmela
Jain, Anisha
Shivamallu, Chandan
Wang, Yu
Gimenez-Capitan, Ana
Molina-Vila, Miguel A.
Nilsson, Jonas
Gonzalez-Cao, Maria
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 195
[44] Treatment of KRAS-Mutant Non-Small Cell Lung Cancer The End of the Beginning for Targeted Therapies
Kaufman, Jacob
Stinchcombe, Thomas E.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (18): : 1835 - 1837
[45] Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
Jeanson, Arnaud
Tomasini, Pascale
Souquet-Bressand, Maxime
Brandone, Nicolas
Boucekine, Mohamed
Grangeon, Mathieu
Chaleat, Solene
Khobta, Natalyia
Milia, Julie
Mhanna, Laurent
Greillier, Laurent
Biemar, Julie
Nanni, Isabelle
Ouafik, L'houcine
Garcia, Stephane
Mazieres, Julien
Barlesi, Fabrice
Mascaux, Celine
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : 1095 - 1101
[46] SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer
Xiaowen Wang
Hong Zhang
Russell Sapio
Jun Yang
Justin Wong
Xin Zhang
Jessie Y. Guo
Sharon Pine
Holly Van Remmen
Hong Li
Eileen White
Chen Liu
Megerditch Kiledjian
Dimitri G. Pestov
X. F. Steven Zheng
Nature Communications, 12
[47] Location of Metastases and Prognosis of Patients with Metastatic KRAS-Mutant Non-Small Cell Lung Cancer
Gutierrez Sainz, L.
Ozaez, I.
Higuera Gomez, O.
Villamayor, J.
Esteban Rodriguez, I.
Regojo Zapata, R. M.
Pelaez Garcia, A.
Heredia Soto, V.
Mendiola, M.
Rosas Alonso, R.
Rodriguez Antolin, C.
Ibanez de Caceres, I.
de Castro Carpeno, J.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S649 - S649
[48] SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer
Wang, Xiaowen
Zhang, Hong
Sapio, Russell
Yang, Jun
Wong, Justin
Zhang, Xin
Guo, Jessie Y.
Pine, Sharon
Van Remmen, Holly
Li, Hong
White, Eileen
Liu, Chen
Kiledjian, Megerditch
Pestov, Dimitri G.
Zheng, X. F. Steven
NATURE COMMUNICATIONS, 2021, 12 (01)
[49] Targeting KRAS mutant non-small cell lung cancer (NSCLC) with deltarasin: A small molecule inhibitor of KRAS-PDEδ interaction.
Zhang, Jun
Xu, Ke
Shin, Dong Moon
Deng, Xingming
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[50] Resistance to KRAS inhibition in advanced non-small cell lung cancer
Sreter, Katherina Bernadette
Catarata, Maria Joana
von Laffert, Maximilian
Frille, Armin
FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →